Monday, November 10, 2025
HomeIndustriesBiotechnology

Biotechnology

GRAIL To Initiate REACH Study To Evaluate Clinical Impact Of GalleriⓇ Multi-Cancer Early Detection (MCED) Test Among The Medicare Population

Prospective, Multi-Center Study Will Assess the Clinical Impact of Galleri® in addition to Currently Recommended Cancer Screenings in the Medicare Population GRAIL, LLC, a healthcare company...

Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges

Roche announced the launch of the LightCycler PRO System based on the proven gold standard technology of the LightCycler Systems that came before it. This new...

Read Magazine’s Weekly Roundup: Discover the Most Recent News From Velo3D, Spryker, Cytovale, Draganfly, GAF Energy And Many More !

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...

Cytovale Secures $84 Million Series C to Advance Commercialization of Transformative Sepsis Diagnostic Tool

Norwest-led Financing Will Bring FDA-Cleared IntelliSep® Test to Hospitals Nationwide to Support Early Detection and Treatment of Serious Condition Cytovale, a commercial-stage medical diagnostics company focused...

Affini-T Therapeutics Appoints Healthcare Capital Markets Veteran Kathy Bergsteinsson, MBA, as Chief Financial Officer

Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, announced the appointment of Kathy Bergsteinsson, MBA,...
0FansLike
0FollowersFollow
spot_img

Hot Topics